Find drugs by alphabetical list:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All
Almirall Slumps After Disappointing Test Results of Forest Lung Treatment - Bloomberg
Almirall Slumps After Disappointing Test Results of Forest Lung TreatmentBloombergThe inhaled drug would compete with Boehringer Ingelheim GmbH's Spiriva treatment for the condition, also known as chronic obstructive pulmonary disease, ...Almirall, Forest COPD drug misses goal in PhIII studyFierceBiotechall 36 news articles��
Alternate therapy for poorly controlled asthma - DoctorNDTV
DoctorNDTVAlternate therapy for poorly controlled asthmaDoctorNDTVAdding Spiriva, known generically as tiotropium bromide, to conventional therapy improves symptoms in patients whose asthma is poorly controlled and gives ...
Pearl Therapeutics Raises $69 Million Series C Financing - PR Newswire (press release)
Genetic Engineering NewsPearl Therapeutics Raises $69 Million Series C FinancingPR Newswire (press release)For more information, please visit www.pearltherapeutics.com. Editor's note: Spiriva® is a registered trademark of Boehringer Ingelheim Pharmaceuticals.Pearl Therapeutics Scores $69M in Series C FinancingGenetic Engineering NewsPearl lands $69M Series C for mid-stage COPD programFierceBiotechPearl Therapeutics clear $69m to aid Respiratory Disease ResearchWIREDVC: Venture Capital & Funding Newsall 14 news articles��
Financings of the Fortnight Ponders Haircuts and Waves Its Freak Flag High - The IN VIVO Blog (blog)
The IN VIVO Blog (blog)Financings of the Fortnight Ponders Haircuts and Waves Its Freak Flag HighThe IN VIVO Blog (blog)The drug is being positioned as superior to Boehringer Ingelheim's Spiriva, the only once daily COPD medicine currently approved in the US which generated ...
Last updated on: Jan 24, 2007
Brand Name: | Spiriva |
Active Ingredient: | Tiotropium bromide |
Strength(s): | 18 mcg |
Dosage Form(s): | Capsule |
Company Name: | Boehringer Ingelheim Pharmaceuticals, Inc. |
Availability: | Prescription only |
*Dated Approved by FDA: | January 30, 2004 |
*Approval by FDA does not mean that the drug is available for consumers at this time.
This information is provided by the U.S. Food & Drug Administration.
For more information about this drug, click here. |
What is Spiriva used for?
Spiriva HandiHaler is used for the treatment of breathing problems in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Spiriva is a maintenance bronchodilator. It helps to keep narrowed airways open. Spiriva does not treat sudden episodes of breathing problems (bronchospasm).
Special Warnings with Spiriva:
General Precautions with Spiriva:
Who should not use Spiriva?
Do not use Spiriva if you:
What should I tell my health care provider?
Tell your health care provider if you:
Tell your health care provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Spiriva may interact with some other medicines used for COPD.
What are some possible side effects of Spiriva? (This list is NOT a complete list of side effects reported with Spiriva. Your health care provider can discuss with you a more complete list of side effects.)
Some common side effects with Spiriva include:
Accupril
Actonel
Actos
Allegra
Altace
Atenolol
Avandia
Celebrex
Celexa
Cialis
Coreg
Cozaar
Crestor
Diovan
Effexor
Evista
Flomax
Fluoxetine
Fosamax
Glucophage
Latisse
Levitra
Levoxyl
Lexapro
Lipitor
Lisinopril
Metformin
Neurontin
Nexium
Norvasc
Paxil
Plavix
Pravachol
Premarin
Prevacid
Prilosec
Propecia
Protonix
Prozac
Seroquel
Simvastatin
Singulair
Toprol-XL
Viagra
Zetia
Zithromax
Zocor
Zoloft
Zyprexa
Zyrtec